The Prescription of Anticraving Medication and its Economic Consequences | Zendy

Rüdiger Holzbach | Zendy; Gunnar Stammen | Zendy; Ute Kirchhof | Zendy; Norbert Scherbaum | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Prescription of Anticraving Medication and its Economic Consequences

Author(s) -

Rüdiger Holzbach,

Gunnar Stammen,

Ute Kirchhof,

Norbert Scherbaum

Publication year - 2019

Publication title -

european addiction research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.862

H-Index - 54

eISSN - 1421-9891

pISSN - 1022-6877

DOI - 10.1159/000500521

Subject(s) - medicine , medical prescription , emergency medicine , inpatient care , addiction , psychiatry , health care , pediatrics , pharmacology , economics , economic growth

According to recent studies, only a small proportion of alcoholics in the system for addiction treatment receive expedited treatment [Rehm et al.: Sucht 2014;60:93-105] and that those who are untreated are at risk of harmful and dependent alcohol consumption. This is associated with significantly negative effects on morbidity, mortality, and quality of life [Kraus et al.: Sucht 2010;56:337-347]. As a result, not only individuals and their environment suffer but there is also a health economic impact.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research